https://www.scmp.com/rss/518063/feed Wuxi AppTec is Asia's largest provider of contract pharmaceutical research, helping drug makers shorten their discovery and development procedures. Its platform is used by more than 6,000 customers, including biotech and pharmaceutical companies, research institutions, researchers, scientists and entrepreneurs in more than 30 countries. The company was founded by Ge Li, who also chairs Wuxi Biologics. en https://assets.i-scmp.com/static/img/icons/scmp-meta-1200x630.png https://www.scmp.com Julie Zhang Julie Zhang Chinese contract drug makers – including WuXi AppTec, WuXi Biologics and WuXi XDC – face a less certain long-term revenue outlook as US pharmaceutical companies bring production in-house and reconfigure supply chains amid rising US-China tensions. While near-term earnings remained largely locked in, visibility beyond that was limited, according to Cui Cui, head of healthcare research for Asia at Jefferies. “Earnings visibility for 2026 and 2027 is still very strong – revenue momentum is largely... https://www.scmp.com/business/china-business/article/3346911/us-reshoring-drive-casts-shadow-over-chinas-contract-drug-makers-analyst?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3346911/us-reshoring-drive-casts-shadow-over-chinas-contract-drug-makers-analyst?utm_source=rss_feed Tue, 17 Mar 2026 11:48:41 +0000 Julie Zhang Julie Zhang A surge in drug research in China has driven the cost of a laboratory monkey to about 140,000 yuan (US$20,260), a sum that exceeds the country’s average annual wage. Official government procurement records showed that prices had doubled in the last five years for such monkeys, which are widely used in the preclinical stage to check whether a drug is safe and how it is absorbed, broken down and cleared by the body. Analysts said the soaring cost was underpinned by a flood of drug-licensing deals... https://www.scmp.com/business/china-business/article/3343819/chinas-biotech-boom-sends-price-lab-monkeys-drug-tests-climbing?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3343819/chinas-biotech-boom-sends-price-lab-monkeys-drug-tests-climbing?utm_source=rss_feed Wed, 18 Feb 2026 09:00:08 +0000 Xinmei Shen,Khushboo Razdan,Vincent Chow Xinmei Shen,Khushboo Razdan,Vincent Chow In a move that escalates tensions between Beijing and Washington just weeks ahead of US President Donald Trump’s anticipated trip to Beijing, the Pentagon added a wide range of Chinese companies to a list of firms with alleged links to the military before withdrawing the document. Giants like Alibaba Group Holding, Baidu and BYD are among the firms added to the list. Alibaba is the parent company of the South China Morning Post. The updated designation also names firms spanning the biotech, AI,... https://www.scmp.com/news/us/article/3343540/pentagon-adds-chinese-firms-military-list-then-withdraws-filing?utm_source=rss_feed https://www.scmp.com/news/us/article/3343540/pentagon-adds-chinese-firms-military-list-then-withdraws-filing?utm_source=rss_feed Fri, 13 Feb 2026 16:36:23 +0000 Cao Li Cao Li Hong Kong stocks rose on Tuesday as global investors broadened their focus beyond US markets, fuelling gains across Asian equities, while the yuan advanced to its strongest level against the US dollar since May 2023. The Hang Seng Index closed 0.9 per cent up at 26,848.47 after earlier gaining more than 2 per cent to 27,143 – its highest since last November. The Hang Seng Tech Index was little changed after advancing more than 2.4 per cent in the morning. On the mainland, the CSI 300 Index and... https://www.scmp.com/business/article/3339662/hong-kong-stocks-climb-yuan-hits-strongest-level-nearly-three-years?utm_source=rss_feed https://www.scmp.com/business/article/3339662/hong-kong-stocks-climb-yuan-hits-strongest-level-nearly-three-years?utm_source=rss_feed Tue, 13 Jan 2026 02:31:47 +0000 Julie Zhang,Eunice Xu Julie Zhang,Eunice Xu If pharmaceutical drug patents are an hourglass turned over on the day of approval – with the approaching loss of exclusivity known in the industry as the “patent cliff” – then Big Pharma is currently watching the final grains of sand slipping through the neck of the glass. At the bottom of the hourglass awaits an unforgiving world of generic and biosimilar competition. Between 2025 and 2030, the patent cliff is set to be one of the biggest since 2010 by revenue at risk, according to... https://www.scmp.com/business/china-business/article/3337038/patent-cliffhanger-will-china-biotech-throw-big-pharma-lifeline?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3337038/patent-cliffhanger-will-china-biotech-throw-big-pharma-lifeline?utm_source=rss_feed Sat, 20 Dec 2025 00:00:10 +0000 Bochen Han Bochen Han Nine Republican lawmakers, including several congressional committee chairs, sent a letter this week urging US Defence Secretary Pete Hegseth to add more than a dozen Chinese technology firms to the Pentagon’s list of companies alleged to have links to the Chinese military. The letter, released on Friday after US President Donald Trump signed a US$900 billion military spending bill restricting US investments into Chinese tech, asks the Pentagon chief to place AI firm DeepSeek, smartphone maker... https://www.scmp.com/news/china/diplomacy/article/3337138/us-lawmakers-want-deepseek-xiaomi-added-list-chinese-military-linked-firms?utm_source=rss_feed https://www.scmp.com/news/china/diplomacy/article/3337138/us-lawmakers-want-deepseek-xiaomi-added-list-chinese-military-linked-firms?utm_source=rss_feed Fri, 19 Dec 2025 17:17:57 +0000 Ling Xin Ling Xin The US Congress passed its annual defence bill on Wednesday, easing concerns among researchers by dropping a controversial proposal targeting US-China scientific collaboration, even as it imposed new restrictions on Chinese biotechnology companies. The SAFE (Securing American Funding and Expertise from Adversarial Research Exploitation) Research Act would have denied federal funding to any US researcher working with scientists from China and several other countries, but it did not make it into... https://www.scmp.com/news/china/science/article/3336886/us-lawmakers-killed-proposal-targeting-science-efforts-china-and-did-instead?utm_source=rss_feed https://www.scmp.com/news/china/science/article/3336886/us-lawmakers-killed-proposal-targeting-science-efforts-china-and-did-instead?utm_source=rss_feed Thu, 18 Dec 2025 13:00:10 +0000 Yulu Ao Yulu Ao Hong Kong stocks closed higher on Wednesday as investors bet on Beijing’s stimulus measures to shore up the property market and broader economy while waiting for clues on the US Federal Reserve’s policy path next year. The Hang Seng Index rose 0.3 per cent to 25,540.78 at the close of trading after falling as much as 0.7 per cent earlier in the session. The Hang Seng Tech Index rose 0.5 per cent. On the mainland, the CSI 300 Index fell 0.1 per cent and the Shanghai Composite Index slipped 0.2... https://www.scmp.com/business/china-business/article/3335827/hong-kong-stocks-extend-losses-wall-street-caution-weighs-sentiment?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3335827/hong-kong-stocks-extend-losses-wall-street-caution-weighs-sentiment?utm_source=rss_feed Wed, 10 Dec 2025 02:25:58 +0000 Yulu Ao Yulu Ao Hong Kong stocks extended their losing run on Tuesday, tracking Wall Street’s overnight pullback, as traders priced in an interest-rate cut but grew uneasy about the pace of reductions expected next year. Sentiment was further dampened after economists at global banks flagged that the latest China Politburo readout suggested “a lack of urgency” for policy stimulus. The Hang Seng Index lost 1.3 per cent to 25,434.23 at the close of trading, adding to the 1.2 per cent loss recorded the previous... https://www.scmp.com/business/china-business/article/3335677/hong-kong-stocks-extend-losses-amid-rate-cut-caution-muted-china-policy-outlook?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3335677/hong-kong-stocks-extend-losses-amid-rate-cut-caution-muted-china-policy-outlook?utm_source=rss_feed Tue, 09 Dec 2025 02:29:29 +0000 Yulu Ao Yulu Ao Hong Kong stocks fell on Monday as investors turned cautious ahead of the long-delayed release of key US economic data, with uncertainty over the Federal Reserve’s rate moves and the artificial intelligence bubble narrative also dampening risk appetite. The Hang Seng Index closed 0.7 per cent lower at 26,384.28, adding to the 1.9 per cent loss on Friday. The Hang Seng Tech Index dropped 1 per cent. On the mainland, the CSI 300 Index retreated 0.7 per cent and the Shanghai Composite Index shed... https://www.scmp.com/business/china-business/article/3333025/hong-kong-stocks-fall-us-data-delay-fed-policy-uncertainty-hit-sentiment?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3333025/hong-kong-stocks-fall-us-data-delay-fed-policy-uncertainty-hit-sentiment?utm_source=rss_feed Mon, 17 Nov 2025 02:22:53 +0000 Yulu Ao Yulu Ao Hong Kong stocks extended losses on Wednesday, tracking Wall Street’s weakness amid growing fears of an artificial intelligence bubble, while uncertainty over the Federal Reserve’s rate-cut trajectory further curbed risk appetite. The Hang Seng Index declined 0.1 per cent to 25,935.41 at the close, adding to the 0.8 per cent loss a day earlier. The Hang Seng Tech Index slumped 0.6 per cent. On the mainland, the CSI 300 Index and the Shanghai Composite Index both added 0.1 per cent. Technology... https://www.scmp.com/business/china-business/article/3331562/hong-kong-stocks-tumble-ai-bubble-fears-hit-wall-street?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3331562/hong-kong-stocks-tumble-ai-bubble-fears-hit-wall-street?utm_source=rss_feed Wed, 05 Nov 2025 02:37:32 +0000 Yulu Ao Yulu Ao Hong Kong stocks advanced on Monday as investors cheered signs of easing tensions between China and the United States after the two nations reached a preliminary framework deal in Kuala Lumpur, raising hopes for further stabilisation in the world’s most important bilateral relationship. The Hang Seng Index climbed 1.1 per cent to 26,433.70 at the close of trading. The Hang Seng Tech Index advanced 1.8 per cent. On the mainland, both the CSI 300 Index and the Shanghai Composite Index added 1.2... https://www.scmp.com/business/china-business/article/3330410/hong-kong-stocks-rise-preliminary-china-us-agreement-boosts-sentiment?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3330410/hong-kong-stocks-rise-preliminary-china-us-agreement-boosts-sentiment?utm_source=rss_feed Mon, 27 Oct 2025 02:02:33 +0000 Yulu Ao Yulu Ao Hong Kong stocks fell on Wednesday, tracking weakness on Wall Street as its recent rally lost momentum, while gold and silver extended their pullback from record highs. Investors also weighed whether US-China tensions could ease after US President Donald Trump offered mixed signals on a potential meeting with his Chinese counterpart Xi Jinping. The Hang Seng Index declined 0.9 per cent to 25,781.77 at the close of trading, erasing the 0.7 per cent gain recorded on Tuesday. The Hang Seng Tech... https://www.scmp.com/business/china-business/article/3329869/hong-kong-stocks-mirror-wall-street-slide-gold-and-silver-extend-retreat?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3329869/hong-kong-stocks-mirror-wall-street-slide-gold-and-silver-extend-retreat?utm_source=rss_feed Wed, 22 Oct 2025 02:23:35 +0000 Zhang Shidong Zhang Shidong Hong Kong stocks fell for a sixth day on Monday, the longest losing streak in nine months, as renewed US-China trade tensions kept investors on edge and dampened risk appetite. The Hang Seng Index closed 1.5 per cent lower at 25,889.48, extending its loss for the last six days to 5.1 per cent and marking the longest losing run since January. The Hang Seng Tech Index dropped 1.8 per cent. On the mainland, the CSI 300 Index fell 0.5 per cent and the Shanghai Composite Index retreated 0.2 per... https://www.scmp.com/business/china-business/article/3328743/hong-kong-stocks-post-longest-decline-9-months-renewed-us-china-tensions?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3328743/hong-kong-stocks-post-longest-decline-9-months-renewed-us-china-tensions?utm_source=rss_feed Mon, 13 Oct 2025 02:50:05 +0000 Xinmei Shen Xinmei Shen US President Donald Trump’s latest round of tariffs targeting imported branded pharmaceutical products would “barely dent” the operations of major Chinese drug makers, according to analysts. The new 100 per cent tariff on any branded or patented pharmaceutical product would apply to all imports, according to Trump’s post on his social media platform Truth Social on Thursday. Exemptions, however, would cover firms that have already broken ground on building a manufacturing plant in the US. Drugs... https://www.scmp.com/tech/tech-trends/article/3327012/trumps-tariffs-imported-drugs-not-big-concern-chinas-pharma-firms-jefferies?utm_source=rss_feed https://www.scmp.com/tech/tech-trends/article/3327012/trumps-tariffs-imported-drugs-not-big-concern-chinas-pharma-firms-jefferies?utm_source=rss_feed Fri, 26 Sep 2025 11:00:10 +0000 Zhang Shidong Zhang Shidong Hong Kong stocks capped the first weekly decline this month as concerns about frothy valuations of global equities unsettled investors and drug makers slid after the Trump administration unveiled a fresh bout of tariffs on the industry. The Hang Seng Index fell 1.4 per cent to 26,128.20 at the close, taking the loss for the week to 1.6 per cent. The Hang Seng Tech Index tumbled 2.9 per cent. On the mainland, the CSI 300 Index slid 1 per cent and the Shanghai Composite Index retreated 0.7 per... https://www.scmp.com/business/china-business/article/3326919/hong-kong-stocks-set-notch-first-weekly-loss-september-valuation-tariff-jitters?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3326919/hong-kong-stocks-set-notch-first-weekly-loss-september-valuation-tariff-jitters?utm_source=rss_feed Fri, 26 Sep 2025 02:20:38 +0000 Yulu Ao Yulu Ao Hong Kong stocks fell on Thursday after the Federal Reserve signalled a conservative approach on the pace of future easing. The Hang Seng Index declined 1.4 per cent to 26,554.85 at the close, after jumping as much as 0.6 per cent to top 27,000 points. The Hang Seng Tech Index slid 1 per cent. On the mainland, the CSI 300 Index slipped 1.4 per cent, while the Shanghai Composite Index lost 1.2 per cent. WeChat operator Tencent Holdings slumped 3 per cent to HK$642, while home appliance producer... https://www.scmp.com/business/china-business/article/3325933/hong-kong-stocks-slip-feds-priced-rate-cut-fails-excite-investors?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3325933/hong-kong-stocks-slip-feds-priced-rate-cut-fails-excite-investors?utm_source=rss_feed Thu, 18 Sep 2025 02:17:59 +0000 Yulu Ao Yulu Ao Hong Kong stocks traded near a four-year high on Tuesday as investors looked for clues on the pace of interest-rate cuts while US President Donald Trump said he would speak with Chinese President Xi Jinping on Friday and the two countries reached an agreement to keep TikTok operating in the US. The Hang Seng Index retreated less than 0.1 per cent to 26,438.51 at the close, after jumping as much as 0.6 per cent earlier, ending the day just shy of Monday’s four-year high. The Hang Seng Tech Index... https://www.scmp.com/business/china-business/article/3325656/hong-kong-stocks-follow-wall-street-rise-us-china-report-tiktok-agreement?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3325656/hong-kong-stocks-follow-wall-street-rise-us-china-report-tiktok-agreement?utm_source=rss_feed Tue, 16 Sep 2025 02:09:50 +0000 Xinmei Shen Xinmei Shen DNA sequencers from Chinese firm MGI Tech can rival those from global market leader Illumina in spite of US sanctions, according to Yin Ye, CEO of BGI Group, former parent of the Shenzhen-based biotech company. MGI’s sequencers offer the best “comprehensive value” in terms of time, quality and cost, Yin said in an interview on the sidelines of the BioHK 2025 conference on Thursday. Yin, 46, pointed out that MGI’s latest product, the DNBSEQ-T7+, is “pushing physics and chemistry to the limit”, as... https://www.scmp.com/tech/big-tech/article/3325235/pushing-physics-limit-mgis-dna-sequencers-gaining-market-bgi-ceo-says?utm_source=rss_feed https://www.scmp.com/tech/big-tech/article/3325235/pushing-physics-limit-mgis-dna-sequencers-gaining-market-bgi-ceo-says?utm_source=rss_feed Thu, 11 Sep 2025 23:00:10 +0000 Zhang Shidong Zhang Shidong A rally that sent Hong Kong stocks to the highest level in four years took a breather, as Chinese drug makers took a pounding amid fears that the Trump administration would impose fresh curbs on medicine exports from the country. The Hang Seng Index closed 0.4 per cent lower at 26,086.32 on Thursday, trimming a decline of as much as 1.2 per cent. The Hang Seng Tech Index slipped 0.2 per cent. A rebound in mainland stocks helped to ease the selling pressure in the city. The CSI 300 Index climbed... https://www.scmp.com/business/china-business/article/3325115/hong-kong-stocks-slip-4-year-high-amid-fears-us-sanctions-chinese-drug-makers?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3325115/hong-kong-stocks-slip-4-year-high-amid-fears-us-sanctions-chinese-drug-makers?utm_source=rss_feed Thu, 11 Sep 2025 02:33:19 +0000 Aileen Chuang Aileen Chuang China’s healthcare sector is on track to secure record fundraising this year, driven by robust global investor demand and growth momentum, according to analysts. Several Chinese biopharmaceutical companies have tapped equity capital markets – mainly in Hong Kong – for initial public offerings (IPOs), follow-on deals and block share placements this year. Year to date, the fundraising reached US$10.6 billion (HK$82.5 billion), more than the combined total from 2022 to 2024, according to Dealogic... https://www.scmp.com/business/china-business/article/3325006/chinas-healthcare-sector-sees-record-us106-billion-fundraising-biotech-booms?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3325006/chinas-healthcare-sector-sees-record-us106-billion-fundraising-biotech-booms?utm_source=rss_feed Wed, 10 Sep 2025 06:25:10 +0000 Alice Li Alice Li In the summer of 2015, a time when China’s pharmaceutical market was in a phase of rapid expansion, a sudden regulatory change sent tremors through the industry: drug companies would need to audit the clinical trial data for all pending applications. If withdrawn within a month of the announcement, firms could avoid penalties for submitting flawed applications, but hiding or falsifying data would court severe punishments, including multi-year filing bans. The response from the industry indicated... https://www.scmp.com/economy/china-economy/article/3324487/chinas-biotech-industry-gaining-us-can-tariffs-hold-them-back?utm_source=rss_feed https://www.scmp.com/economy/china-economy/article/3324487/chinas-biotech-industry-gaining-us-can-tariffs-hold-them-back?utm_source=rss_feed Fri, 05 Sep 2025 22:00:13 +0000 Yulu Ao Yulu Ao Mainland Chinese stocks advanced on Friday, with a key benchmark rising to a ten-year high, as investors believe that the momentum driven by a rotation from fixed-income investments will continue. The Shanghai Composite Index closed up 1.5 per cent at 3,825.76, the highest since August 17, 2015 and pushing the weekly gain to 3.4 per cent. The CSI 300 Index closed 2.1 per cent higher, taking the increase for the five-day period to 4.1 per cent. The weekly gains for both the benchmarks were the... https://www.scmp.com/business/china-business/article/3322736/hong-kong-stocks-set-third-weekly-gain-investors-await-fed-meeting-outcome?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3322736/hong-kong-stocks-set-third-weekly-gain-investors-await-fed-meeting-outcome?utm_source=rss_feed Fri, 22 Aug 2025 02:43:12 +0000 SCMP Editorial SCMP Editorial It’s been a long time coming but mainland Chinese stocks have risen to their highest in a decade amid appealing valuations and low deposit rates. The strength of the rally surprised some but may be seen as a delayed effect from last September when the government launched a comprehensive stimulus package, after an off-schedule Politburo meeting that further signalled Beijing’s resolve to stimulate growth. That triggered a stock market rally but it did not last. Now, however, with strong corporate... https://www.scmp.com/opinion/comment/article/3322647/stimulus-beds-chinese-stock-rally-may-have-legs?utm_source=rss_feed https://www.scmp.com/opinion/comment/article/3322647/stimulus-beds-chinese-stock-rally-may-have-legs?utm_source=rss_feed Thu, 21 Aug 2025 23:15:09 +0000 Eric Ng Eric Ng Wuxi AppTec, Asia’s largest provider of contract pharmaceutical research, has raised HK$7.70 billion (US$981 million) through a sale of additional shares in Hong Kong as it rides the wave of bullish appetite for Chinese biotechnology shares. The Shanghai-based company sold 73.8 million new shares to institutional investors at HK$104.27 each, a 6.9 per cent discount to the previous day’s closing price of HK$112 on Wednesday, it said in a filing to Hong Kong’s bourse on Thursday. The stock fell... https://www.scmp.com/business/article/3320237/wuxi-apptec-raises-us981-mn-hong-kong-offer-amid-growing-appetite-chinese-biotech?utm_source=rss_feed https://www.scmp.com/business/article/3320237/wuxi-apptec-raises-us981-mn-hong-kong-offer-amid-growing-appetite-chinese-biotech?utm_source=rss_feed Thu, 31 Jul 2025 04:44:09 +0000 Zhang Shidong Zhang Shidong A solid run for Hong Kong stocks showed signs of slowing, as the city’s benchmark closed at a two-week low after the US Federal Reserve appeared resistant to an imminent interest rate cut and China’s manufacturing sector shrank unexpectedly. The Hang Seng Index fell 1.6 per cent to 24,773.33 at the close on Thursday, a level not seen since July 17. Still, the gauge achieved a third monthly gain, rising 2.9 per cent in July, as China-US tensions eased and after better-than-expected economic... https://www.scmp.com/business/china-business/article/3320210/hong-kong-stocks-head-2-week-low-fed-rate-decision-and-china-manufacturing-data?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3320210/hong-kong-stocks-head-2-week-low-fed-rate-decision-and-china-manufacturing-data?utm_source=rss_feed Thu, 31 Jul 2025 02:31:35 +0000 Zhang Shidong Zhang Shidong The run-up that drove Hong Kong stocks to the highest level in more than three and a half years continued on Wednesday after the US pencilled in a fresh round of trade talks with China for next week and clinched a deal with Japan, reducing concerns about damage to the global economy and corporate earnings. The Hang Seng Index rose for a fourth day, gaining 1.6 per cent to 25,538.07 for the highest close since November 17, 2021. The Hang Seng Tech Index gained 2.5 per cent. On the mainland, the... https://www.scmp.com/business/china-business/article/3319216/hong-kong-stocks-sustain-3-year-high-level-headway-trade-talks-spurs-optimism?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3319216/hong-kong-stocks-sustain-3-year-high-level-headway-trade-talks-spurs-optimism?utm_source=rss_feed Wed, 23 Jul 2025 02:24:07 +0000 Alice Li Alice Li As the dust barely settles on “Made in China 2025”, Beijing is intensifying its quest for technological supremacy with a focus on “future industries” amid its escalating rivalry with the United States. Authorities are pushing boundaries in their pursuit of a new growth model centred on technological breakthroughs and industrial upgrades. What are “future industries”? First introduced by President Xi Jinping in 2020, the term refers to sectors with foundational technologies still in their infancy... https://www.scmp.com/economy/china-economy/article/3317889/what-are-chinas-future-industries-and-why-they-matter-global-tech-race?utm_source=rss_feed https://www.scmp.com/economy/china-economy/article/3317889/what-are-chinas-future-industries-and-why-they-matter-global-tech-race?utm_source=rss_feed Sun, 13 Jul 2025 01:00:08 +0000 Zhang Shidong Zhang Shidong Hong Kong stocks advanced on Friday, with the city’s benchmark pulling off a weekly gain on expectations for improved earnings in some industries and additional policy support from Beijing to spur growth. The Hang Seng Index rose 0.5 per cent to 24,139.57 at the close and the Hang Seng Tech Index gained 0.6 per cent. On the mainland, the CSI 300 Index added 0.1 per cent and the Shanghai Composite Index was little changed. Wuxi AppTec jumped 10 per cent to HK$88.15 after saying its first-half... https://www.scmp.com/business/companies/article/3317788/hong-kong-stocks-head-weekly-gain-earnings-optimism-wuxi-apptec-rallies?utm_source=rss_feed https://www.scmp.com/business/companies/article/3317788/hong-kong-stocks-head-weekly-gain-earnings-optimism-wuxi-apptec-rallies?utm_source=rss_feed Fri, 11 Jul 2025 02:19:14 +0000 Yulu Ao Yulu Ao Chinese onshore stocks rose for a second day to near a three-month high after private sector reports showed signs of recovery in manufacturing activity and home sales amid government efforts to shore up the economy. The CSI 300 Index, which tracks the biggest companies listed in Shanghai and Shenzhen, added 0.2 per cent to 3,942.76 on Tuesday. The gauge reached 3,960.07 on June 25, the highest level since March 20. The Shanghai Composite Index added 0.4 per cent. Financial markets in Hong Kong... https://www.scmp.com/business/china-business/article/3316454/chinese-stocks-trade-near-3-month-high-manufacturing-home-sales-rebound?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3316454/chinese-stocks-trade-near-3-month-high-manufacturing-home-sales-rebound?utm_source=rss_feed Tue, 01 Jul 2025 02:36:32 +0000 Zhang Shidong Zhang Shidong Hong Kong stocks capped a sixth straight weekly gain on optimism that a de-escalation in US-China tensions will dispel the gloom surrounding China’s growth outlook, alongside last month’s data pointing to a mild ongoing recovery. The Hang Seng Index closed 0.2 per cent higher at 23,601.26. The benchmark added 1.1 per cent this week, the longest winning stretch in three months. The Hang Seng Tech Index slipped 0.1 per cent. On the mainland, the CSI 300 Index dropped 0.8 per cent and the Shanghai... https://www.scmp.com/business/china-business/article/3311469/hong-kong-stocks-track-sixth-week-gains-upbeat-china-outlook?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3311469/hong-kong-stocks-track-sixth-week-gains-upbeat-china-outlook?utm_source=rss_feed Fri, 23 May 2025 02:42:08 +0000 Wency Chen Wency Chen China is rapidly advancing its technological self-sufficiency in semiconductors and biotechnology, a trend accelerated by escalating trade tensions with the US, industry experts said in a webinar hosted by the South China Morning Post’s China Future Tech. “We need to be ready to see a world that will be increasingly polarised, basically with the bifurcation in supply chains, which could be about manufacturing, which could be about data flows … could be about investment,” said Gary Ng, senior... https://www.scmp.com/tech/big-tech/article/3309589/how-chinas-self-sufficiency-drive-dividing-global-tech-ecosystem?utm_source=rss_feed https://www.scmp.com/tech/big-tech/article/3309589/how-chinas-self-sufficiency-drive-dividing-global-tech-ecosystem?utm_source=rss_feed Thu, 08 May 2025 09:48:54 +0000 Aileen Chuang Aileen Chuang Hong Kong stocks rose slightly on Tuesday, as traders kept an eye on the latest developments in the US-China tariff talks and corporate results to assess the impact of the ongoing trade war. The Hang Seng Index closed 0.2 per cent higher at 22,008.11. The Hang Seng Tech Index gained 0.6 per cent. On the mainland, the CSI 300 Index dropped 0.2 per cent and the Shanghai Composite Index fell 0.1 per cent. Chinese biotech firm WuXi AppTec rose 4.2 per cent to HK$60.65 after net income beat analysts’... https://www.scmp.com/business/markets/article/3308288/hong-kong-stocks-rise-investors-await-earnings-hsbc-icbc-china-construction-bank?utm_source=rss_feed https://www.scmp.com/business/markets/article/3308288/hong-kong-stocks-rise-investors-await-earnings-hsbc-icbc-china-construction-bank?utm_source=rss_feed Tue, 29 Apr 2025 02:40:01 +0000 Eric Ng Eric Ng China’s biomedical sector faces uncertainties in 2025, ranging from potential tariff hikes on exports of medical devices to the United States to potential passage of a US national security law that would ban new government contracts with some major Chinese biotech equipment and service providers. China boasts the world’s second-largest biomedical sector after the US, which is also the largest market for China’s medical device exports. The US accounted for a quarter of China’s total US$19.7... https://www.scmp.com/plus/article/3294636/plus-exclusive-chinas-biomedical-sector-finds-reprieves-through-new-markets-and-lapsed-us-biosecure?utm_source=rss_feed https://www.scmp.com/plus/article/3294636/plus-exclusive-chinas-biomedical-sector-finds-reprieves-through-new-markets-and-lapsed-us-biosecure?utm_source=rss_feed Tue, 14 Jan 2025 03:43:03 +0000 Reuters Reuters China’s WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to US drug maker Merck & Co for about US$500 million, ahead of potential US legislation that would restrict business for Chinese biotech companies. The US House of Representatives passed the Biosecure Act in September, which would ban federal contracts with targeted firms and their business partners. The legislation, which explicitly names WuXi, must pass the US Senate before it can be sent to the president to be... https://www.scmp.com/news/china/article/3293656/chinas-wuxi-biologics-sell-irish-vaccine-facility-merck-us-curbs-loom?utm_source=rss_feed https://www.scmp.com/news/china/article/3293656/chinas-wuxi-biologics-sell-irish-vaccine-facility-merck-us-curbs-loom?utm_source=rss_feed Mon, 06 Jan 2025 19:34:55 +0000 Bloomberg Bloomberg Shares of Chinese biotech service providers WuXi AppTec and WuXi Biologics surged on Monday, after a draft US legislation seeking to eliminate their linchpin role in global drug development missed its last big window for passage into law this year. WuXi AppTec’s shares rose as much as 12 per cent in early trading in Hong Kong on Monday, lifting the stock to the highest level in two months. WuXi Biologics gained as much as 13 per cent, while MGI Tech climbed 4.3 per cent in Shanghai. The absence... https://www.scmp.com/tech/tech-war/article/3289970/wuxi-apptec-wuxi-biologics-surge-slimmer-chances-us-biosecure-acts-passage?utm_source=rss_feed https://www.scmp.com/tech/tech-war/article/3289970/wuxi-apptec-wuxi-biologics-surge-slimmer-chances-us-biosecure-acts-passage?utm_source=rss_feed Mon, 09 Dec 2024 06:40:39 +0000 Wency Chen Wency Chen Shanghai’s municipal government seeks to encourage local biopharmaceutical firms to get their products certified by the US Food and Drug Administration and European Medicines Agency, as part of a broad plan to enhance the city’s “international competitiveness” in this field. According to the government’s 2024-2027 action plan published on Thursday, Shanghai will boost support for local biopharmaceutical companies to have their drugs and medical devices approved in overseas markets. This... https://www.scmp.com/tech/tech-trends/article/3284674/shanghai-support-local-biopharma-firms-overseas-push-regulatory-product-compliance?utm_source=rss_feed https://www.scmp.com/tech/tech-trends/article/3284674/shanghai-support-local-biopharma-firms-overseas-push-regulatory-product-compliance?utm_source=rss_feed Thu, 31 Oct 2024 23:00:15 +0000 Zhou Xin Zhou Xin Shares of WuXi AppTec and WuXi Biologics surged in Hong Kong on Friday, following a report that the two firms are looking to divest some of their operations in the wake of new United States legislation targeting Chinese biotech companies. WuXi AppTec’s shares closed up almost 12 per cent to HK$67.10 on Friday, while shares of subsidiary WuXi Biologics rose nearly 15 per cent to HK$21.45. Those gains were made after Financial Times, citing people familiar with the matter, reported on Thursday... https://www.scmp.com/news/article/3281119/wuxi-apptec-wuxi-biologics-surge-hong-kong-biotech-firms-put-some-operations-sale?utm_source=rss_feed https://www.scmp.com/news/article/3281119/wuxi-apptec-wuxi-biologics-surge-hong-kong-biotech-firms-put-some-operations-sale?utm_source=rss_feed Fri, 04 Oct 2024 10:00:09 +0000 A senior American official on Thursday lauded improved cooperation with the Chinese government on export controls meant to prevent the transfer of sensitive technologies to the mainland. Since the end of coronavirus lockdowns in China, mainland authorities have been more helpful in conducting “end-user checks” on companies that buy products sold by US firms, said Matthew Axelrod, assistant secretary for export enforcement at the US Commerce Department. These US firms are under greater pressure... https://www.scmp.com/news/china/article/3278322/senior-us-official-praises-chinas-cooperation-export-controls-technology-transfers?utm_source=rss_feed https://www.scmp.com/news/china/article/3278322/senior-us-official-praises-chinas-cooperation-export-controls-technology-transfers?utm_source=rss_feed Thu, 12 Sep 2024 19:40:42 +0000 The US House may vote this week on more than two dozen China-related bills on the floor, including legislation that could close Hong Kong’s diplomatic offices stateside and restrict government contracting with world-leading mainland biotech firms. In total, 28 measures scheduled this week by the Republican-led House reference or focus on competing with China, addressing issues ranging from countering Beijing’s tech, political and economic influence to bolstering American allies in the... https://www.scmp.com/news/china/article/3277569/china-week-us-house-puts-biotech-firms-hong-kong-offices-legislative-cross-hairs?utm_source=rss_feed https://www.scmp.com/news/china/article/3277569/china-week-us-house-puts-biotech-firms-hong-kong-offices-legislative-cross-hairs?utm_source=rss_feed Sun, 08 Sep 2024 15:59:08 +0000 A bipartisan group of lawmakers on Tuesday called on the Biden administration to ramp up scrutiny of US clinical trials conducted in China, citing the risk of intellectual property theft and the possibility of forced participation of Uygurs. Republican John Moolenaar, who chairs the House Select Committee on China, and senior Democrat Raja Krishnamoorthi said US drug companies have collaborated with Chinese military-run hospitals to conduct hundreds of clinical trials over the last decade,... https://www.scmp.com/news/world/united-states-canada/article/3275248/us-clinical-trials-china-draw-questions-ip-theft-forced-uygur-involvement?utm_source=rss_feed https://www.scmp.com/news/world/united-states-canada/article/3275248/us-clinical-trials-china-draw-questions-ip-theft-forced-uygur-involvement?utm_source=rss_feed Tue, 20 Aug 2024 18:43:10 +0000 Hong Kong stocks slipped, extending a retreat from a three-month high, as weak corporate earnings and guidance weighed on sentiment and Chinese authorities stayed away from major stimulus measures to rejuvenate the economy. The Hang Seng Index declined 1.2 per cent to 16,529.48 at the close on Tuesday. The Tech Index fell 1.8 per cent, while the Shanghai Composite Index lost 0.7 per cent. WuXi AppTech tumbled 7.5 per cent to HK$39.55, the lowest level in over a month, after the company gave... https://www.scmp.com/business/markets/article/3255873/hong-kong-stocks-slip-weak-chinese-corporate-earnings-wuxi-apptech-wuxi-biologics-xpeng-leading?utm_source=rss_feed https://www.scmp.com/business/markets/article/3255873/hong-kong-stocks-slip-weak-chinese-corporate-earnings-wuxi-apptech-wuxi-biologics-xpeng-leading?utm_source=rss_feed Tue, 19 Mar 2024 02:28:17 +0000 An influential panel in the US House of Representatives on Thursday urged sweeping restrictions on outbound investment in Chinese biotechnology, as it pushed for the advancement of a bill to restrict the industry’s operations in the American market. The hearing held by the House select committee on competition with China came after a Senate committee voted 11-1 on Wednesday backing a companion bill prohibiting US federally-funded institutions from contracting with certain biotech providers in... https://www.scmp.com/news/china/article/3254590/time-cut-us-outbound-investment-china-biotech-firms-bgi-group-and-wuxi-apptec-house-panel?utm_source=rss_feed https://www.scmp.com/news/china/article/3254590/time-cut-us-outbound-investment-china-biotech-firms-bgi-group-and-wuxi-apptec-house-panel?utm_source=rss_feed Thu, 07 Mar 2024 22:05:33 +0000 The US should review Chinese biotech firm Wuxi AppTec and its affiliate Wuxi Biologics for sanctions, a bipartisan group of lawmakers told top Biden administration officials on Monday. In a letter dated February 12 and seen by Reuters, the lawmakers told Treasury Secretary Janet Yellen, Defence Secretary Lloyd Austin and Commerce Secretary Gina Raimondo that the global pharmaceutical giant’s links to China’s Communist Party and military threatened US national security. The letter, signed by the... https://www.scmp.com/business/china-business/article/3251803/chinese-biotech-firm-wuxi-apptec-should-be-sanctioned-security-threat-us-lawmakers-tell-white-house?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3251803/chinese-biotech-firm-wuxi-apptec-should-be-sanctioned-security-threat-us-lawmakers-tell-white-house?utm_source=rss_feed Tue, 13 Feb 2024 03:42:46 +0000 Chinese electric vehicle (EV) maker Li Auto and pharmaceutical company WuXi Apptec will join the Hang Seng Index as new constituents in December, according to the latest quarterly review by Hong Kong’s index compiler. The new additions will increase the number of index members to 82 from 80, index compiler Hang Seng Indexes, a subsidiary of Hang Seng Bank, said in a statement on Friday after the market close. The changes will be effective from December 4, it added. The additions mark a third... https://www.scmp.com/business/china-business/article/3241959/chinese-ev-maker-li-auto-and-pharmaceutical-firm-wuxi-apptec-join-hong-kongs-benchmark-hang-seng?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3241959/chinese-ev-maker-li-auto-and-pharmaceutical-firm-wuxi-apptec-join-hong-kongs-benchmark-hang-seng?utm_source=rss_feed Fri, 17 Nov 2023 11:16:07 +0000 Insilico Medicine, a Hong Kong-based artificial intelligence (AI) biotechnology company, hopes to add momentum to the city’s health technology industry with the development of its AI-discovered drug. The company announced late last month that it had initiated phase I clinical trials for its first AI-discovered antifibrotic product candidate. The announcement came as Hong Kong is trying to build itself into an innovation and technology hub – it coincided with a government announcement that it... https://www.scmp.com/business/china-business/article/3170083/wuxi-apptec-warburg-pincus-backed-ai-drug-firm-insilico?utm_source=rss_feed https://www.scmp.com/business/china-business/article/3170083/wuxi-apptec-warburg-pincus-backed-ai-drug-firm-insilico?utm_source=rss_feed Sun, 13 Mar 2022 04:00:22 +0000 Tighter US government scrutiny of Chinese investment in US biotechnology companies will not dent its interest in pursuing investment opportunities there, said executives of Wuxi AppTec, Asia’s largest provider of contract pharmaceutical research. “It is not a problem, we will just make the necessary filings according to the legal requirements,” board secretary Yao Chi said at a press conference on Friday to announced the company’s Hong Kong listing plan. The Shanghai-based firm aims to raise up... https://www.scmp.com/business/article/2175888/leading-chinese-biotech-firm-wuxi-apptec-says-us-hurdles-will-not-dim?utm_source=rss_feed https://www.scmp.com/business/article/2175888/leading-chinese-biotech-firm-wuxi-apptec-says-us-hurdles-will-not-dim?utm_source=rss_feed Sat, 01 Dec 2018 00:32:11 +0000 WuXi AppTec, the mainland’s leading biotechnology firm, has announced a plan to sell shares in Hong Kong, just two months after it went public in Shanghai via a fast-tracked listing. The board has approved a plan for a listing on the main board of the Hong Kong stock exchange, and the new shares will account for 10 per cent to 15 per cent of its enlarged share total, the company said in a filing to the Shanghai Stock Exchange on Sunday. Chinese biotech firm Ascletis first to apply for Hong Kong... https://www.scmp.com/business/companies/article/2153317/after-fast-track-shanghai-listing-mainland-biotech-firm-wuxi?utm_source=rss_feed https://www.scmp.com/business/companies/article/2153317/after-fast-track-shanghai-listing-mainland-biotech-firm-wuxi?utm_source=rss_feed Sun, 01 Jul 2018 23:30:46 +0000 Wuxi AppTec, China’s biggest contract medical researcher that floated in May, has made the unusual move of issuing a statement warning its share price is rising too fast and its valuation is excessive. The company closed at 107.36 yuan on Friday in Shanghai, rising by the allowed daily maximum of 10 per cent for the 13th straight session. Its share price has now surged almost five-fold from its initial public offering price. “The company’s price-to-earnings ratio is relatively high compared with... https://www.scmp.com/business/companies/article/2147848/wuxi-apptec-tells-chinese-investors-go-slow-obsession-unicorns?utm_source=rss_feed https://www.scmp.com/business/companies/article/2147848/wuxi-apptec-tells-chinese-investors-go-slow-obsession-unicorns?utm_source=rss_feed Fri, 25 May 2018 10:22:17 +0000 WuXi AppTec, the mainland’s leading biotechnology firm which privatised in New York two years ago, has been given the green light to relist on the A-share market via an initial public offering (IPO) in Shanghai, just seven weeks after filing its application. The listing is expected to raise more than 5.7 billion yuan (US$907.5 million), which the firm will use to expand research facilities and build new plants. The lighting-fast approval adds further evidence that competition among exchanges in... https://www.scmp.com/business/companies/article/2139187/wuxi-apptec-given-green-light-raise-us907m-shanghai-ipo?utm_source=rss_feed https://www.scmp.com/business/companies/article/2139187/wuxi-apptec-given-green-light-raise-us907m-shanghai-ipo?utm_source=rss_feed Tue, 27 Mar 2018 15:45:30 +0000